Please use this identifier to cite or link to this item:
https://dora.health.qld.gov.au/qldresearchjspui/handle/1/676
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Millard, F. | en |
dc.contributor.author | Harrington, V. | en |
dc.date.accessioned | 2018-06-16T20:36:48Z | - |
dc.date.available | 2018-06-16T20:36:48Z | - |
dc.date.issued | 2008 | en |
dc.identifier.citation | 2008 May 37, (5), 2008, p. 297 | en |
dc.identifier.other | RIS | en |
dc.identifier.uri | http://dora.health.qld.gov.au/qldresearchjspui/handle/1/676 | - |
dc.description.abstract | The first author comments on a previous article on GP management of dementia that gives some misleading information on cognitive testing and ability to prescribe cholinesterase inhibitors. The author of the original paper replies. (non-author abstract)Aust Fam Physician, 2008 May; 37 (5): 297Anl <br /> | en |
dc.language | en | en |
dc.relation.ispartof | Australian Family Physician | en |
dc.title | Management of dementia. -letter | en |
dc.type | Article | en |
dc.subject.keywords | Dementia, diagnosis ;Neuropsychological Tests, standardsAustralia ;Cholinesterase Inhibitors, therapeutic use ;Dementia, drug therapy ;Family Practice ;Humans ;Psychometrics | en |
dc.relation.url | http://www.racgp.org.au/Content/NavigationMenu/Publications/AustralianFamilyPhys/2008issues/afp200805/200805letters.pdf | en |
dc.identifier.risid | 361 | en |
dc.description.pages | 297 | en |
item.openairetype | Article | - |
item.cerifentitytype | Publications | - |
item.grantfulltext | none | - |
item.openairecristype | http://purl.org/coar/resource_type/c_18cf | - |
item.fulltext | No Fulltext | - |
Appears in Sites: | Sunshine Coast HHS Publications |
Items in DORA are protected by copyright, with all rights reserved, unless otherwise indicated.